PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID

The present invention relates to: a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid or a pharmaceutically acceptable salt thereof; and a method for preventing or treating hyperuricemia-related diseases using same. The pharmaceutical composition of t...

Full description

Saved in:
Bibliographic Details
Main Authors GWAK, Heemin, LEE, Jieun, SHIN, Seong Hye, KIM, Junyu, MIN, Ji Young, MUNE, June Sik, KIM, Min Hee, SEO, Jung Youn
Format Patent
LanguageEnglish
Published 14.12.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to: a pharmaceutical composition comprising 1-(3-cyano-1-isopropyl-indol-5-yl)pyrazole-4-carboxylic acid or a pharmaceutically acceptable salt thereof; and a method for preventing or treating hyperuricemia-related diseases using same. The pharmaceutical composition of the present invention may effectively reduce the uric acid level in the blood of a patient who has a hyperuricemia-related disease.
Bibliography:Application Number: AU20220292402